Thromboenangitis of parietal abacterial disease occurs in people without obvious causes of the disease. It is an acute inflammatory disease that can lead to heart failure and thromboembolism. To detect the disease, blood and urine tests can be performed to detect the presence of Epstein-Barr virus antibodies, which
**Parietal abacterial thromboendocaritis (TEPA)** is an acute or subacute systemic inflammatory disease that affects the endocardial layers. TEPA is usually characterized by the presence of string-like fibrin deposits on the endocardium, which can lead to arterial occlusion. TEPA is usually a complication of rheumatic heart disease and can lead to heart attacks and sudden death. Treatment for TEPA includes antibiotics, antiarrhythmic drugs, anticoagulants, and vascular therapy. In severe cases, surgery may be required to repair the heart valve.